pCPA Activity Overview

Status Total Negotiations Summary
Active Negotiations 30 Non-oncology: 20
Oncology: 10
Under Consideration for Negotiation 18 Non-oncology: 12
Oncology: 6
Completed Negotiations 384 With Letter of Intent: 331
Without agreement: 53
Negotiations That Were Not Pursued 79

pCPA Activity in the last four weeks

Activity for the last four weeks. Please note that these updates may take one to two weeks to be processed.

Engagement Letters Issued in the last four weeks

Brand Name Manufacturer Indication Engagement Date
Vocabria and Cabenuva VIIV HEALTHCARE ULC HIV Infection
Entyvio (SC) Takeda Canada Inc. Ulcerative Colitis
Erleada Janssen Inc. Metastatic Castration-Sensitive Prostate Cancer
Crysvita Ultragenyx Canada Inc. X-Linked Hypophosphatemia
Aermony Respiclick Teva Canada Limited Asthma

Negotiations Completed in the last four weeks with a Letter of Intent

Brand Name Manufacturer Indication Engagement Date Close Date
Kanuma Alexion Pharma GMBH Lysosomal acid lipase deficiency
Admelog Sanofi-aventis Canada Inc. Diabetes Mellitus, Type 1 & 2

Negotiations Completed in the last four weeks without Agreement

Brand Name Manufacturer Indication Engagement Date Close Date
No negotiations completed without agreement in the last four weeks

Negotiations that pCPA Decided Not to Pursue in the last four weeks

Brand Name Manufacturer Indication Close Date
Cablivi SANOFI-AVENTIS acquired thrombotic thrombocytopenic purpura (aTTP)
Contrave Bausch Health, Canada Inc. Chronic weight management